Related Experiment Videos
Spermatocyte selection during meiosis following mitomycin C treatment in mice
Experientia
|December 15, 1978
Abstract:
In mice treated with mitomycin C, elimination of spermatocytes is observed during meiotic division, whereby an increase in number of the eliminated cells is closely related to an increase in the frequency of spermatocytes with chromosome aberrations at M-I.
Insights
Mitomycin C treatment causes spermatocyte elimination during meiosis in mice. This cell loss correlates with increased chromosome aberrations in spermatocytes during M-I.
Area of Science:
- Reproductive biology
- Genetics
- Toxicology
Background:
- Spermatogenesis is a complex process involving meiosis.
- Environmental and chemical factors can induce germ cell abnormalities.
- Mitomycin C is a known genotoxic agent.
Purpose of the Study:
- To investigate the effects of mitomycin C on male meiosis in mice.
- To determine the relationship between chromosome aberrations and spermatocyte elimination.
Main Methods:
- Mice were treated with mitomycin C.
- Spermatocytes were analyzed during meiotic division (M-I).
- Chromosome aberrations and cell elimination rates were quantified.
Main Results:
- Mitomycin C induced significant elimination of spermatocytes during meiosis.
- An increased frequency of spermatocytes with chromosome aberrations at M-I was observed.
- The number of eliminated spermatocytes was directly related to the frequency of chromosome aberrations.
Conclusions:
- Mitomycin C disrupts male meiosis by inducing chromosome aberrations, leading to spermatocyte loss.
- This study highlights the sensitivity of meiotic processes to genotoxic agents.
- Findings suggest potential risks of reproductive toxicity associated with mitomycin C exposure.